Skip to main content

SIGNET FINANCIAL MANAGEMENT, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1600307 PARSIPPANY, NJ

Position in REGN

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$3,009,432
-$56,435 QoQ
Shares Held
3,895
-1.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SIGNET FINANCIAL MANAGEMENT, LLC holds $3,009,432 across 1 Biotechnology name. REGN ranks #1 (100.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
This page
3,895 $3,009,432

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,009,432 3,895
2025-12-31 $3,065,867 3,972
2025-09-30 $2,246,268 3,995
2025-06-30 $2,091,075 3,983
2025-03-31 $2,538,822 4,003
2024-12-31 $2,792,333 3,920
2024-09-30 $4,236,497 4,030
2024-06-30 $4,230,395 4,025
2024-03-31 $3,869,209 4,020
2023-12-31 $3,462,219 3,942
2023-09-30 $3,244,931 3,943
2023-06-30 $2,866,256 3,989
2023-03-31 $3,257,921 3,965
2022-12-31 $2,852,771 3,954
2022-09-30 $2,746,524 3,987
2022-06-30 $2,345,012 3,967
2022-03-31 $2,770,632 3,967
2021-12-31 $2,473,032 3,916
2021-09-30 $2,344,467 3,874
2021-06-30 $2,157,640 3,863
2021-03-31 $1,829,632 3,867
2020-12-31 $1,930,507 3,996
2020-09-30 $2,296,777 4,103
2020-06-30 $2,683,565 4,303
2020-03-31 $2,342,815 4,798